The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
Open accessAbstract
We established an international consortium to review and discuss relevant clinical evidence in order to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2-related disease (COVID-19) pandemic. The steering committee prepared 10 working packages addressing significant clinical questions from diagnosis to surgery. During a virtual consensus meeting of 62 global experts and one patient advocate, led by the European Society for Medical Oncology, statements were discussed, amended and voted upon. When consensus could not be reached, the panel revised statements until a consensus was reached. Overall, the expert panel agreed on 28 consensus statements that can be used to overcome many of the clinical and technical areas of uncertainty ranging from diagnosis to therapeutic planning and treatment during the COVID-19 pandemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Tang, N., Li, D., Wang, X., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14768 · Cited by 5,662
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., Li, C., Ai, Q., Lu, W., Liang, H., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30096-6 · Cited by 4,384
How will country-based mitigation measures influence the course of the COVID-19 epidemic?
Anderson, R. M., Heesterbeek, H., Klinkenberg, D., & Hollingsworth, T. D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30567-5 · Cited by 3,648
Fair Allocation of Scarce Medical Resources in the Time of Covid-19
Emanuel, E. J., Persad, G., Upshur, R., Thome, B., Parker, M., Glickman, A., Zhang, C., Boyle, C., Smith, M., & Phillips, J. P. (2020) · New England Journal of Medicine · doi:10.1056/nejmsb2005114 · Cited by 3,137
Virtually perfect? Telemedicine for COVID-19
Hollander, J. E., & Carr, B. G. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2003539 · Cited by 2,970
Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)
Gomes, C. A. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2,134
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Kuderer, N. M., Choueiri, T. K., Shah, D. P., Shyr, Y., Rubinstein, S. M., Rivera, D. R., Shete, S., Hsu, C.-Y., Desai, A., de Lima Lopes, G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31187-9 · Cited by 1,726
Self-citationDai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., Zhang, Z., You, H., Wu, M., Zheng, Q., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0422 · Cited by 1,589
Self-citationBujko, K., Nowacki, M. P., Nasierowska-Guttmejer, A., Michalski, W., Bebenek, M., & Kryj, M. (2006) · British Journal of Surgery · doi:10.1002/bjs.5506 · Cited by 1,244
Lee, L. Y., Cazier, J.-B., Angelis, V., Arnold, R., Bisht, V., Campton, N. A., Chackathayil, J., Cheng, V. W., Curley, H. M., Fittall, M. W., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31173-9 · Cited by 1,103
SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
Yu, J., Ouyang, W., Chua, M. L. K., & Xie, C. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.0980 · Cited by 1,071
Self-citationSimpson, S., Kay, F. U., Abbara, S., Bhalla, S., Chung, J. H., Chung, M., Henry, T. S., Kanne, J. P., Kligerman, S., Ko, J. P., et al. (2020) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000524 · Cited by 773
Hematologic parameters in patients with COVID‐19 infection
Fan, B. E., Chong, V. C. L., Chan, S. S. W., Lim, G. H., Lim, K. G. E., Tan, G. B., Mucheli, S. S., Kuperan, P., & Ong, K. H. (2020) · American Journal of Hematology · doi:10.1002/ajh.25774 · Cited by 769
Simpson, S., Kay, F. U., Abbara, S., Bhalla, S., Chung, J. H., Chung, M., Henry, T. S., Kanne, J. P., Kligerman, S., Ko, J. P., et al. (2020) · Radiology: Cardiothoracic Imaging · doi:10.1148/ryct.2020200152 · Cited by 752
Kim, H., Hong, H., & Yoon, S. H. (2020) · Radiology · doi:10.1148/radiol.2020201343 · Cited by 539
Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal
Ueda, M., Martins, R., Hendrie, P. C., McDonnell, T., Crews, J. R., Wong, T. L., McCreery, B., Jagels, B., Crane, A., Byrd, D. R., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.7560 · Cited by 514
Special report: The simulations driving the world’s response to COVID-19
Adam, D. (2020) · Nature · doi:10.1038/d41586-020-01003-6 · Cited by 441
Risk of COVID-19 for patients with cancer
Xia, Y., Jin, R., Zhao, J., Li, W., & Shen, H. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30150-9 · Cited by 432
Chaft, J. E., Oxnard, G. R., Sima, C. S., Kris, M. G., Miller, V. A., & Riely, G. J. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1468 · Cited by 418
Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City
Miyashita, H., Mikami, T., Chopra, N., Yamada, T., Chernyavsky, S., Rizk, D., & Cruz, C. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.04.006 · Cited by 379
Caring for patients with cancer in the COVID-19 era
van de Haar, J., Hoes, L. R., Coles, C. E., Seamon, K., Fröhling, S., Jäger, D., Valenza, F., de Braud, F., De Petris, L., Bergh, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0874-8 · Cited by 330
Self-citationThe Global Dynamic Interventions Strategies for COVID-19 Collaborative Group, Chowdhury, R., Heng, K., Shawon, M. S. R., Goh, G., Okonofua, D., Ochoa-Rosales, C., Gonzalez-Jaramillo, V., Bhuiya, A., Reidpath, D., et al. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00649-w · Cited by 275
Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control
Lee, C. Y.-P., Lin, R. T. P., Renia, L., & Ng, L. F. P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00879 · Cited by 260
Waterhouse, D. M., Harvey, R. D., Hurley, P., Levit, L. A., Kim, E. S., Klepin, H. D., Mileham, K. F., Nowakowski, G., Schenkel, C., Davis, C., et al. (2020) · JCO Oncology Practice · doi:10.1200/op.20.00275 · Cited by 199
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer
de Azambuja, E., Trapani, D., Loibl, S., Delaloge, S., Senkus, E., Criscitiello, C., Poortmans, P., Gnant, M., Di Cosimo, S., Cortes, J., et al. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-000793 · Cited by 176
Self-citationESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer
Passaro, A., Addeo, A., von Garnier, C., Blackhall, F. H., Planchard, D., Felip, E., Dziadziuszko, R., de Marinis, F., Reck, M., Bouchaab, H., et al. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-000820 · Cited by 140
Self-citationSARS-CoV-2 shedding and infectivity
Atkinson, B., & Petersen, E. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30868-0 · Cited by 137
PKB/Akt-dependent regulation of inflammation in cancer
Tang, F., Wang, Y., Hemmings, B. A., Rüegg, C., & Xue, G. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.04.018 · Cited by 125
Immunological effects of BRAF+MEK inhibition
Ascierto, P. A., & Dummer, R. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1468955 · Cited by 88
Self-citationUnger, J. M., Blanke, C. D., LeBlanc, M. L., & Hershman, D. L. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.10651 · Cited by 80
Rostamzadeh, D., Yousefi, M., Haghshenas, M. R., Ahmadi, M., Dolati, S., & Babaloo, Z. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28042 · Cited by 70
The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19
Anil, I., Arnold, R. R., Benkwitz-Beford, S., Branford, S., Campton, N. A., Cazier, J., Cheng, V. W. T., Curley, H. M., D'Costa, J., Edmondson, A., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30230-8 · Cited by 60
Neamatallah, T. (2019) · Journal of Microscopy and Ultrastructure · doi:10.4103/jmau.jmau_68_18 · Cited by 58
Nawar, T., Morjaria, S. M., Kaltsas, A., Patel, D. M., Pérez-Johnston, R., Daniyan, A. F., Mailankody, S., & Parameswaran, R. (2020) · American Journal of Hematology · doi:10.1002/ajh.25870 · Cited by 53
A Precision Medicine Approach to SARS-CoV-2 Pandemic Management
Crisci, C. D., Ardusso, L., Mossuz, A., & Müller, L. (2020) · Current Treatment Options in Allergy · doi:10.1007/s40521-020-00258-8 · Cited by 42
Die Bedeutung der Bestrahlungspause
Feldmann, H. J. (2000) · Strahlentherapie und Onkologie · doi:10.1007/pl00002310 · Cited by 7
Changing Oncology Treatment Paradigms in the COVID-19 Pandemic
Lou, E., & Subramanian, S. (2020) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2020.05.002 · Cited by 5
Oncology Treatment in the Era of COVID‐19: We Cannot Afford to Hit the Pause Button
Holstein, S. A., & Vose, J. M. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1920 · Cited by 3
Cited by
Remote Psychological Interventions for Fear of Cancer Recurrence: Scoping Review.
Cincidda, C., Pizzoli, S. F. M., & Pravettoni, G. (2022) · JMIR Cancer · doi:10.2196/29745 · Cited by 34
“Furthermore, during the pandemic, the management of patients with cancer has raised medical issues [14,15] and psychological issues [16].”
BackgroundKoinig, K. A., Arnold, C., Lehmann, J., Giesinger, J., Köck, S., Willenbacher, W., Weger, R., Holzner, B., Ganswindt, U., Wolf, D., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3950 · Cited by 34
“Myelodysplastic syndromes (MDS) 24 (10)”
Mostafaei, A., Sadeghi-Ghyassi, F., Kabiri, N., & Hajebrahimi, S. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07415-6 · Cited by 22
Metadata
- Authors
- Curigliano, G., Banerjee, S., Cervantes, A., Garassino, M. C., Garrido, P., Girard, N., Haanen, J., Jordan, K., Lordick, F., Machiels, J. P., Michielin, O., Peters, S., Tabernero, J., Douillard, J. Y., Pentheroudakis, G., Addeo, A., Albiges, L., Ascierto, P. A., Banerjee, S., Barlesi, F., Caldas, C., Cardoso, F., Cervantes, A., Chaberny, I. F., Cherny, N. I., Choueiri, T. K., Chua, M. L. K., Criscitiello, C., Curigliano, G., de Azambuja, E., De Ruysscher, D., de Vries, E., Dent, R., Douillard, J. Y., D’Ugo, D., Dziadziuszko, R., Faivre-Finn, C., Felip, E., Garassino, M., Garrido, P., Girard, N., Glynne-Jones, R., Golfinopoulos, V., Haanen, J., Hamilton, E., Jänne, P. A., Jordan, K., Kanesvaran, R., Kim, S. B., Liebert, U. G., Lordick, F., Machiels, J. P., Michielin, O., Mok, T. S. K., Morgan, G., Obermannova, R., Park, K., Passaro, A., Pentheroudakis, G., Peters, S., Reck, M., Salazar Soler, R., Scotté, F., Senan, S., Sessa, C., Smyth, E., Soo, R., Soria, J. C., Spicer, J., Strasser, F., Tabernero, J., Tan, D. S. W., Trapani, D., Van Cutsem, E., van Halteren, H., van Schil, P. E., Veronesi, G., & Yang, J.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 31
- Issue
- 10
- Pages
- 1320-1335
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W3046565762
- Cited by
- 307
- References
- 40
- FWCI
- 20.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.